Seres Therapeutics, Inc.

MCRB

$8.80

Name : Seres Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $84,359,424.00

EPSttm : 0.63

Seres Therapeutics, Inc.

$8.80

2.22%

$0.2

MCRB — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

8.84

Margin Of Safety %

Put/Call OI Ratio

0.36

EPS Next Q Diff

-0.22

EPS Last/This Y

-8.87

EPS This/Next Y

-0.94

Price

8.85

Target Price

Analyst Recom

Performance Q

-39.93

Upside

19.7%

Beta

0.24

Ticker: MCRB

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	MCRB	9.06	0.37	0.17	6237
2026-03-03	MCRB	8.83	0.37	0.17	6237
2026-03-04	MCRB	9.15	0.37	0.19	6241
2026-03-05	MCRB	9.59	0.37	999.99	6231
2026-03-06	MCRB	9.06	0.37	0.25	6233
2026-03-09	MCRB	9.19	0.37	0.00	6241
2026-03-10	MCRB	9.01	0.37	0.03	6254
2026-03-11	MCRB	8.8	0.37	0.18	6318
2026-03-12	MCRB	8.99	0.37	0.00	6320
2026-03-13	MCRB	9.05	0.37	0.00	6320
2026-03-17	MCRB	9.44	0.36	0.38	6300
2026-03-18	MCRB	9.15	0.36	6.00	6306
2026-03-19	MCRB	9.07	0.36	999.99	6303
2026-03-20	MCRB	8.55	0.36	999.99	6307
2026-03-23	MCRB	8.59	0.36	0.00	6217
2026-03-24	MCRB	8.46	0.36	0.27	6225
2026-03-25	MCRB	9.2	0.36	0.08	6224
2026-03-26	MCRB	9.32	0.36	0.33	6309
2026-03-27	MCRB	9.08	0.36	2.67	6314
2026-03-30	MCRB	8.92	0.36	999.99	6323
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	MCRB	9.01	27.3	-	0.77
2026-03-03	MCRB	8.86	27.3	-	0.77
2026-03-04	MCRB	9.11	27.3	-	0.77
2026-03-05	MCRB	9.60	27.3	-	0.77
2026-03-06	MCRB	9.18	27.3	-	0.77
2026-03-09	MCRB	9.17	27.3	-	0.77
2026-03-10	MCRB	8.94	27.3	-	0.77
2026-03-11	MCRB	8.93	27.3	-	0.77
2026-03-12	MCRB	8.95	27.3	-	0.77
2026-03-13	MCRB	8.64	-	-	-7.97
2026-03-17	MCRB	9.42	-	-	-7.97
2026-03-18	MCRB	9.06	-	-	-7.97
2026-03-19	MCRB	8.95	-	-	-7.97
2026-03-20	MCRB	8.49	16.0	-	-8.23
2026-03-23	MCRB	8.59	16.0	-	-8.23
2026-03-24	MCRB	8.37	16.0	-	-8.23
2026-03-25	MCRB	9.14	16.0	-	-8.23
2026-03-26	MCRB	9.34	16.0	-	-8.23
2026-03-27	MCRB	9.10	16.0	-	-8.23
2026-03-30	MCRB	8.85	16.0	-	-8.23
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	MCRB	-0.13	3.73	11.54
2026-03-03	MCRB	-0.13	3.73	11.54
2026-03-04	MCRB	-0.13	3.73	11.54
2026-03-05	MCRB	-0.13	3.73	11.54
2026-03-06	MCRB	-0.13	3.73	11.54
2026-03-09	MCRB	-0.13	3.73	11.54
2026-03-10	MCRB	-0.13	3.73	11.54
2026-03-11	MCRB	-0.13	3.73	9.76
2026-03-12	MCRB	-0.13	3.73	9.76
2026-03-13	MCRB	-0.13	3.73	9.76
2026-03-17	MCRB	-0.12	3.51	9.21
2026-03-18	MCRB	-0.12	3.51	9.21
2026-03-19	MCRB	-0.12	3.51	9.21
2026-03-20	MCRB	-0.12	3.51	9.21
2026-03-23	MCRB	-0.12	3.54	9.21
2026-03-24	MCRB	-0.12	3.54	9.21
2026-03-25	MCRB	-0.12	3.54	8.84
2026-03-26	MCRB	-0.12	3.54	8.84
2026-03-27	MCRB	-0.12	3.54	8.84
2026-03-30	MCRB	-0.12	3.54	8.84
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.89

Avg. EPS Est. Current Quarter

-1.88

Avg. EPS Est. Next Quarter

-2.11

Insider Transactions

-0.12

Institutional Transactions

3.54

Beta

0.24

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

12.88

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.2

Max Drawdown 5-Year %

-98.6

Target Price

P/E

10.86

Forward P/E

PEG

P/S

106.79

P/B

1.9

P/Free Cash Flow

98.1

EPS

0.81

Average EPS Est. Cur. Y

-8.23

EPS Next Y. (Est.)

-9.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

721.93

Relative Volume

0.8

Return on Equity vs Sector %

-14.6

Return on Equity vs Industry %

1.7

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

2.2

EBIT Estimation

◆ MCRB Healthcare

$8.80

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

17/25

Volume

7/15

Valuation

15/20

TP/AR

2/10

Options

6/10

RSI

43.1

Range 1M

54.4%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

10/30

Estimates

0/20

Inst/Vol

4/15

Options

7/10

EPS Yr

-1385.9%

EPS NY

-11.4%

52W%

10.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +87.8% upside

Quality

5/30

Valuation

23/30

Growth

5/25

Stability

4/10

LT Trend

4/5

Upside

+87.8%

Quality

MoS

46%

Seres Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 66

Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

MCRB

Latest News

—

Caricamento notizie per MCRB…

stock quote shares MCRB – Seres Therapeutics, Inc. Stock Price stock today

news today MCRB – Seres Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch MCRB – Seres Therapeutics, Inc. yahoo finance google finance

stock history MCRB – Seres Therapeutics, Inc. invest stock market

stock prices MCRB premarket after hours

ticker MCRB fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MCRB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y